Pre-Launch Checklist: What To Look For In A Commercialization Partner

The pre-launch window is one of the most consequential periods in a therapy's lifecycle, and the decisions you make about partnership during this phase have long reach. This checklist walks you through nine specific questions worth pressure-testing with any prospective commercialization partner, covering evidence gap remediation through real-world evidence studies, HEOR application for payer dialogue, internal stakeholder alignment across dispersed teams, logistics scalability, web-enabled order visibility, and reimbursement pathway guidance.
Beyond the nine questions, a few broader qualities separate genuinely integrated partners from those who simply aggregate services: a demonstrated patient-first investment philosophy, global reach paired with localized field expertise, and a track record of solving for complexity rather than sidestepping it.
Asking a prospective partner how they've handled prior launch challenges is one of the more reliable ways to surface that capability. Whether you're preparing for a first commercial launch or scaling an existing portfolio, use these questions to evaluate where your current or prospective partner stands.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.